Sumitomo Dainippon Pharma Co Ltd - Other Operating Expenses

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Other-Operating-Expenses" stands at 156.69 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.

Sumitomo Dainippon Pharma Co Ltd's first quarter result of 35.66 Billion JPY for the item "Other Operating Expenses" represents a decrease of -4.34 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 35.66 Billion JPY for the item "Other Operating Expenses" represents a decrease of -21.99 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 156.69 Billion JPY for the item "Other Operating Expenses" represents a decrease of -6.03 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 73.24 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 73.24 Billion Japanese Yens.
The 3 year change is 147.63 Billion Japanese Yens.
The 5 year change is 145.36 Billion Japanese Yens.
The 10 year change is 16.06 Billion Japanese Yens.

The Serie's long term average value is 77.07 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 79.62 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 06/30/2023, to it's latest available value, on 06/30/2025, is +197.79 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2014, to it's latest available value, on 06/30/2025, is -22.21 Billion.